| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.03 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.03 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.099 | 0.06 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |